Rebalix
Logo UBSUBS · sheet of 10 September 2026
ETF sheet · official issuer and register data

UBS Core MSCI Europe UCITS ETF USD acc

LU3254395307 · LU3254395307 · USD · domicile Luxembourg
Equity · EuropeSFDR art. 6
Index tracked: MSCI Europe (TRN) in USD
TER
0.06%+ trans. 0.01%
Fund size
49 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 4 Mar 2026 · costs from the KID as of 2 Sept 2026 · 0 securities held

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the MSCI Europe Index (Net Return) either through direct investments in all or substantially all of the component securities and/or through the use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments or in order to generate efficiencies in gaining exposure to the index. There may also be instances where a sub-fund holds securities which are not comprised in its index if the portfolio manager of…

Performance since series start (in euro) — base 100

4 Mar 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
11094109
High 110 (7 Aug 2026) · low 94 (20 Mar 2026) · last 109. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+8.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU3254395307 · LU32543953071
RebalixLU3254395307 · LU3254395307 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 21.0%
Top holdingsWeight
ASML HLDG4.5%
HSBC HOLDINGS (GB)2.6%
ROCHE HOLDING PART2.2%
NOVARTIS2.0%
NESTLE1.8%
ASTRAZENECA1.8%
SHELL1.8%
SIEMENS1.7%
BANCO SANTANDER1.4%
SAP1.3%
Countries (% of fund)
Regno Unito22.6%Francia15.3%Svizzera14.5%Germania13.6%Paesi Bassi8.8%
Sectors (% of fund)
Finanza25.6%Industriali18.9%Salute12.9%Informatica8.7%Beni di prima necessita'8.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_LU3254395307_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_LU3254395307_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU3254395307
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU3254395307 · LU32543953072